Clinical trial
Addition of Lactobacillus to Metronidazole in Treatment of CDAD
NCT00304863 · Michael E. DeBakey VA Medical Center, U.S. Fed · Withdrawn
Key facts
| NCT number | NCT00304863 |
|---|---|
| Title | Addition of Lactobacillus to Metronidazole in Treatment of CDAD |
| Official title | Addition of a Probiotic (Lactobacillus GG) to Metronidazole for the Treatment of Clostridium Difficile Associated Disease |
| Lead sponsor | Michael E. DeBakey VA Medical Center, U.S. Fed |
| Collaborators | Baylor College of Medicine |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Enterocolitis, Pseudomembranous Colitis, Antibiotic-associated Colitis |
| Intervention type | Drug |
| Interventions | Lactobacillus GG |
| Enrollment | 0 |
| Start date | Aug 1, 2008 |
| Primary completion | Jul 31, 2010 |
| Completion | Jul 31, 2010 |
| First posted | Mar 20, 2006 |
| Last update posted | May 10, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: